Discordant associations of educational attainment with ASD and ADHD implicate a polygenic form of pleiotropy by Verhoef, Ellen et al.
Supplementary Information 
 
Discordant associations of educational attainment with ASD and ADHD implicate a polygenic  
form of pleiotropy 
 
Supplementary Notes ............................................................................................................................... 3 
Supplementary Note 1: Risk-allele concordance between GWAS summary statistics ......................... 3 
Supplementary Note 2: MVR specificity analyses for adult-onset psychiatric disorders ..................... 4 
Supplementary Note 3: Web resources ............................................................................................... 5 
Supplementary Tables .............................................................................................................................. 6 
Supplementary Table 1: Discovery ASD-MVR (5x10-8<Pthr<0.5) ........................................................... 6 
Supplementary Table 2: Discovery ADHD-MVR (5x10-8<Pthr<0.5) ........................................................ 7 
Supplementary Table 3: Discovery ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), model fit ...... 8 
Supplementary Table 4: Discovery ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), concordant 
variants ................................................................................................................................................ 9 
Supplementary Table 5: Genetic correlations among psychiatric disorders ...................................... 10 
Supplementary Table 6: Genetic correlations of psychiatric disorders with educational attainment 11 
Supplementary Table 7: Follow-up ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), analyses with 
ASD(PGC) SNP estimates (independent variable) .............................................................................. 12 
Supplementary Table 8: Follow-up ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05) with ASD(PGC) 
SNP estimates (independent variable), concordant variants ............................................................. 13 
Supplementary Table 9: ASD-MVR and ADHD-MVR with variants from LD blocks with high posterior 
probability for pleiotropy ................................................................................................................... 14 
Supplementary Table 10: Identification of single variants using conditional P-value thresholding: 
ASD-MVR ........................................................................................................................................... 15 
Supplementary Table 11: Identification of single variants using conditional P-value thresholding: 
ADHD-MVR ........................................................................................................................................ 16 
Supplementary Table 12: Permutation analysis ................................................................................ 17 
Supplementary Table 13: Gene-set enrichment analysis ................................................................... 18 
Supplementary Table 14: Sample description for MDD, SCZ, BD and general intelligence ............... 19 
Supplementary Table 15: Specificity analyses related to general intelligence (dependent variable) 
using ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05) .................................................................. 20 
Supplementary Table 16: Specificity analyses related to risk for other psychiatric disorders 
(independent variable), ASD-MVR (Pthr<0.0015; Pthr<0.05) ................................................................ 21 
Supplementary Table 17: Specificity analyses related to risk for other psychiatric disorders 
(independent variable), ADHD-MVR (Pthr<0.0015; Pthr<0.05) ............................................................. 22 
Supplementary Table 18: Genetic correlations of ASD and ADHD with general intelligence ............ 23 




Supplementary Figures ........................................................................................................................... 25 
Supplementary Figure 1: MVR study design ...................................................................................... 27 
Supplementary Figure 2: Bivariate analyses of ASD, ADHD and EA genetic effects using ASD and 
ADHD concordant variant sets ........................................................................................................... 28 
Supplementary Figure 3: Evidence for pleiotropy and co-localisation using gwas-pw ...................... 29 
Supplementary Figure 4: Genes annotated within pleiotropic genomic segments ........................... 30 
Supplementary Figure 5: Cross-disorder associations with educational attainment for other 
disorders ............................................................................................................................................ 31 
Supplementary Figure 6: Genetic correlations with EA for cross-disorder meta-analyses ................ 33 




Supplementary Note 1: Risk-allele concordance between GWAS summary statistics 
Discovery analyses (Supplementary Figure 1a-b).  
Among the 1,973 SNPs selected at Pthr<0.0015 in ASD(iPSYCH, woADHD), 87% had concordant 
effects with ADHD(iPSYCH). Among the 35,921 SNPs selected at Pthr <0.05 in ASD(iPSYCH, woADHD), 
80% had concordant effects with ADHD(iPSYCH). Likewise, among the 2,717 SNPs selected at threshold 
Pthr<0.0015 in ADHD(iPSYCH), 88% had concordant effects with ASD(iPSYCH, woADHD). Among the 
41,334 SNPs selected at threshold Pthr<0.05 in ADHD(iPSYCH), 78% had concordant effects with 
ASD(iPSYCH, woADHD). 
Follow-up analyses with ASD(PGC) (Supplementary Figure 1c-d).  
Among the 1,973 SNPs selected at Pthr<0.0015 in ASD(iPSYCH, woADHD), 1,886 were available 
in ASD(PGC) and 49% had concordant effects. Among the 35,921 SNPs selected at Pthr<0.05 in 
ASD(iPSYCH, woADHD), 33,845 were available in ASD(PGC) and 52% had concordant effects. Among the 
2,717 SNPs selected at threshold Pthr<0.0015 in ADHD(iPSYCH), 2,627 were available in ASD(PGC) and 
51% had concordant effects. Among the 41,334 SNPs selected at threshold Pthr<0.05 in ADHD(iPSYCH), 
38,656 were available in ASD(PGC) and 52% had concordant effects. 
Specificity analyses related to risk for other psychiatric disorder (Supplementary Figure 1k-l).  
Among the SNPs selected at Pthr<0.0015 in ASD(iPSYCH, woADHD), 2,644 were available in 
MDD(PGC) and 75% had concordant effects, 1,786 were available in SCZ(PGC) and 53% had concordant 
effects, and 1,859 were available in BD(PGC) and 54% had concordant effects. Among the SNPs selected 
at Pthr<0.05 in ASD(iPSYCH, woADHD), 50,904 were available in MDD(PGC) and 65% had concordant 
effects, 31,026 were available in SCZ(PGC) and 52% had concordant effects, and 32,367 were available 
in BD(PGC) and 52% had concordant effects.  
Among the SNPs selected at Pthr<0.0015 in ADHD(iPSYCH), 2,567 were available in MDD(PGC) 
and 77% had concordant effects, 2,278 were available in SCZ(PGC) and 55% had concordant effects, and 
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2,340 were available in BD(PGC) and 52% had concordant effects. Among the SNPs selected at Pthr<0.05 
in ADHD(iPSYCH), 38,093 were available in MDD(PGC) and 68% had concordant effects, 31,395 were 
available in SCZ(PGC) and 52% had concordant effects, and 32,788 were available in BD(PGC) and 51% 
had concordant effects. 
 
Supplementary Note 2: MVR specificity analyses for adult-onset psychiatric disorders 
As part of exploratory specificity analyses, we investigated whether EA-related variation across 
ASD and ADHD genetic architectures is shared with adult-onset psychiatric conditions. We applied ASD- 
and ADHD-MVR using SNP estimates for major depressive disorder (MDD), schizophrenia (SCZ) and 
bipolar disorder (BD) aligned to ASD-related (Gi) and ADHD-related (Gj) variants, respectively (multiple-
testing-adjusted significance threshold: 0.0042 (0.05/12)) (Supplementary Figure 1k-l).  
These analyses showed that all studied adult-onset psychiatric disorders share EA-related 
variation with either an ASD or ADHD genetic architecture, or both, especially at the relaxed P-value 
threshold (Pthr<0.05; Supplementary Figure 5, Supplementary Table 18-19). The strongest discordant 
association pattern with EA was detected for ASD-related risk alleles in combination with MDD risk (ASD-
MVR at Pthr<0.05: 𝜃𝜃�*MDD=-0.012, SE=0.001, P<1x10-10, Supplementary Table 18), and for ADHD-related 
risk alleles in combination with BD risk (ADHD-MVR at Pthr<0.05: 𝜃𝜃�#BD=0.008, SE=0.001, P<1x10-10, 
Supplementary Table 19). All MVR effects were consistent with known LDSC genetic correlations 
(Supplementary Table 5-6). The observed discordant association effects with EA were weaker and 
smaller for adult-onset disorders compared to discovery ASD- and ADHD-MVR effects, although they are 
likely to be inflated due to sample overlap with EA(SSGAC). Meta-analysing summary statistics for pairs 
of disorders with discordant EA-related polygenic effects, while allowing for sample overlap, accurately 
predicted the attenuation of genetic correlations with EA (Supplementary Figure 6), especially between 
ADHD(iPSYCH) and BD(PGC). This may suggest universal genetic mechanisms across EA-related genomic 
regions, where identical GWAS marker alleles capture disorder-specific subthreshold risk effects that 
result in independent polygenic associations with EA.  
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Supplementary Note 3: Web resources 
CTG lab: https://ctg.cncr.nl/software/summary_statistics 
FUMA: https://fuma.ctglab.nl/  












Supplementary Table 1: Discovery ASD-MVR (5x10-8<Pthr<0.5) 
Variant selection Intercept ASD effect ADHD effect 




3ǂ 5x10-8 NA NA NA NA NA NA 
5 5x10-7 -0.010(0.007) 0.28 0.10(0.065) 0.26 -0.015(0.028) 0.65 
26 5x10-6 0.004(0.003) 0.16 -0.003(0.030) 0.93 -0.022(0.024) 0.38 
121 5x10-5 0.001(0.001) 0.38 0.010(0.013) 0.44 -0.018(0.014) 0.22 
816 0.0005 2x10-4(4x10-4) 0.54 0.015(0.005) 0.002 -0.064(0.006) 10-8 
1,973 0.0015 0.001(2x10-4) 0.008 0.009(0.003) 0.002 -0.029(0.004) <10-10 
5,399 0.005 5x10-4(10-4) 3x10-4 0.010(0.002) 6x10-9 -0.028(0.002) <10-10 
35,921 0.05 3x10-4(4x10-5) <10-10 0.007(0.001) <10-10 -0.022(0.001) <10-10 
62,589 0.1 2x10-4(3x10-5) 2x10-10 0.007(0.001) <10-10 -0.020(0.001) <10-10 
134,210 0.3 1x-10-4(2x10-5) 3x10-9 0.007(4x10-4) <10-10 -0.018(4x10-4) <10-10 
185,632 0.5 10-4(2x10-5) <10-10 0.007(4x10-4) <10-10 -0.017(3x10-4) <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; NSNPs, number of SNPs; Pthr, P-value threshold; woADHD, without ADHD 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Supplementary Figure 1a). Sets of independent ASD (Gi) variants were selected 
from ASD(iPSYCH, woADHD). SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) and EA(SSGAC) 
GWAS statistics respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual effect estimates, 
standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0023. 
 
ǂ MVR analyses for ASD-related variants (Pthr<5x10-8) did not converge.  
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Supplementary Table 2: Discovery ADHD-MVR (5x10-8<Pthr<0.5) 
Variant selection Intercept ADHD effect ASD effect 
Gj NSNPs Pthr 𝜃𝜃�0#(SE) P 𝜃𝜃�ADHD(SE) P 𝜃𝜃�#ASD(SE) P 
ADHD 
(iPSYCH) 
10 5x10-8 -0.006(0.017) 0.76 -0.068(0.16) 0.68 0.12(0.075) 0.16 
22 5x10-7 -0.002(0.006) 0.70 -0.055(0.060) 0.37 0.061(0.044) 0.19 
61 5x10-6 -0.003(0.002) 0.13 -0.048(0.024) 0.054 0.096(0.026) 5x10-4 
242 5x10-5 -0.003(0.001) 0.001 -0.013(0.011) 0.24 0.025(0.012) 0.036 
1,202 0.0005 -0.002(3x10-4) 2x10-6 -0.015(0.004) 0.001 0.023(0.005) 2x10-6 
2,717 0.0015 -0.002(2x10-4) <10-10 -0.012(0.003) 4x10-5 0.022(0.003) <10-10 
6,781 0.005 -0.001(10-4) <10-10 -0.009(0.002) 5x10-8 0.018(0.002) <10-10 
41,334 0.05 -0.001(4x10-5) <10-10 -0.009(0.001) <10-10 0.013(0.001) <10-10 
71,015 0.1 -0.001(3x10-5) <10-10 -0.009(0.001) <10-10 0.012(0.001) <10-10 
164,083 0.3 -3x10-4(2x10-5) <10-10 -0.010(4x10-4) <10-10 0.010(3x10-4) <10-10 
234,530 0.5 -2x10-4(10-5) <10-10 -0.011(4x10-4) <10-10 0.009(3x10-4) <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; NSNPs, number of SNPs; Pthr, P-value threshold; woADHD, without ADHD 
 
Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-MVR (Supplementary Figure 1b). Sets of independent ADHD (Gj) genetic variants 
were selected from ADHD(iPSYCH) GWAS statistics. SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), 
ADHD(iPSYCH) and EA(SSGAC) GWAS statistics respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD 




Supplementary Table 3: Discovery ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), model fit 
ASD-MVR 
Variant selection Intercept ASD effect ADHD effect 
VIF 
MVR to UVR model fit 
comparison 





0.001(2x10-4) 0.008 -5x10-6(0.003) 1.00 - - - 
0.001(2x10-4) 0.008 0.009(0.003) 0.002 -0.029(0.004) <10-10 1.19 3.0 167.06, <10-10 
35,921 0.05 
3x10-4(4x10-5) 10-9 0.001(0.001) 0.17 - - - 
3x10-4(4x10-5) <10-10 0.007(0.001) <10-10 -0.022(0.001) <10-10 1.11 2.1 1533.8, <10-10 
ADHD-MVR 
Variant selection Intercept ADHD effect ASD effect 
VIF 
MVR to UVR model fit 
comparison 




-0.001(2x10-4) <10-10 -0.004(0.003) 0.16 - - - 
-0.002(2x10-4) <10-10 -0.012(0.003) 4x10-5 0.022(0.003) <10-10 1.18 1.9 154.24, <10-10 
41,334 0.05 
-0.001(4x10-5) <10-10 -0.004(0.001) <10-10 - - - 
-0.001(4x10-5) <10-10 -0.009(0.001) <10-10 0.013(0.001) <10-10 1.11 0.9 744.05, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number of SNPs; Pthr, P-value threshold; VIF, variance inflation factor; woADHD, without ADHD; UVR, univariable regression; 
∆R2, difference in Regression R2 between MVR and UVR 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Figure 2a, Supplementary Figure 1a). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with 
ADHD-MVR (Figure 2b, Supplementary Figure 1b). Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics 
respectively and are shown for two P-value thresholds (Pthr<0.0015, Pthr<0.05). SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) 
and EA(SSGAC) GWAS statistics respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual effect estimates, standard 





Supplementary Table 4: Discovery ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), concordant variants  
ASD-MVR 
Variant selection Intercept ASD effect ADHD effect VIF 
MVR to UVR model fit comparison 
ASD UVR ADHD UVR 
Concordant 
variants Gi 





4x10-4(2x10-4) 0.15 0.001(0.003) 0.76 - - - 
0.001(2x10-4) 4x10-10 - -0.018(0.004) 9x10-6 - - 
4x10-4(2x10-4) 0.12 0.011(0.003) 0.001 -0.026(0.005) 5x10-8 1.40 1.7 79.67, 4x10-8 0.6 27.06, 0.001 
28,086 0.05 
3x10-5(5x10-5) 0.49 0.001(0.001) 0.11 - - - 
5x10-4(3x10-5) <1x10-10  -0.014(0.001) <10-10 - - 
10-4(5x10-5) 0.054 0.009(0.001) <10-10 -0.020(0.001) <10-10 1.36 1.1 579.37, <10-10 0.4 203.75, <10-10 
ADHD-MVR 
Variant selection Intercept ADHD effects ASD effect VIF 
MVR to UVR model fit comparison 
ADHD UVR ASD UVR 
Concordant 
variants Gj 




-0.001(2x10-4) 8x10-10 -0.004(0.003) 0.16 - - - 
-0.002(1x10-4) <1x10-10 - 0.014(0.003) 3x10-5 - - 
-0.001(2x10-4) 2x10-10 -0.013(0.003) 4x10-5 0.022(0.004) 10-8 1.36 1.3 92.59, 10-8 0.7 48.75, 4x10-5 
32,176 0.05 
-4x10-4(5x10-5) <10-10 -0.005(0.001) 3x10-10 - - - 
-9x10-4(3x10-5) <1x10-10 - 0.007(9x10-4) <10-10 - - 
-0.001(5x10-5) <10-10 -0.011(0.001) <10-10 0.013(0.001) <10-10 1.36 0.5 339.16, <10-10 0.5 290.13, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number of SNPs; Pthr, P-value threshold; VIF, variance inflation factor; woADHD, without ADHD; UVR, univariable 
regression; ∆R2, difference in Regression R2 between UVR and MVR 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Supplementary Figure 1a). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-
MVR (Supplementary Figure 1b). Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected at two P-value thresholds (Pthr<0.0015, Pthr<0.05) from ASD(iPSYCH, woADHD) and 
ADHD(iPSYCH) GWAS statistics respectively and restricted to SNPs with concordant allelic effects. SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, 
woADHD), ADHD(iPSYCH) and EA(SSGAC) GWAS statistics respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual 
effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0023. The model fit of MVRs and UVRs was 
compared with likelihood-ratio tests (LRTs). 
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Supplementary Table 5: Genetic correlations among psychiatric disorders 
Sample 1 Sample 2 rg (SE) P 
ASD(iPSYCH, woADHD)  
ASD(PGC) 0.84(0.11) <10-10 
ADHD(iPSYCH) 0.30 (0.06) 2x10-7 
MDD(PGC) 0.43 (0.05) <10-10 
SCZ(PGC) 0.21 (0.06) 10-4 
BD(PGC) 0.18 (0.06) 0.001 
ASD(PGC) 
ADHD(iPSYCH) 0.04(0.08) 0.61 
MDD(PGC) 0.12(0.05) 0.017 
SCZ(PGC) 0.20(0.06) 0.001 
BD(PGC) 0.12(0.06) 0.063 
ADHD(iPSYCH) 
MDD(PGC) 0.55 (0.04) <10-10 
SCZ(PGC) 0.12 (0.04) 0.004 
BD(PGC) 0.12 (0.05) 0.007 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; iPSYCH, 
The Lundbeck Foundation Initiative for Integrative Psychiatric Research; MDD; Major Depressive Disorder; PGC, Psychiatric 
Genomics Consortium; rg, genetic correlation; SCZ, Schizophrenia; woADHD, without ADHD 
Genetic correlations (rg) among psychiatric disorder samples were estimated using summary statistics and unconstrained LD 
score correlation1. Individual genetic correlation estimates, standard errors and corresponding P-values (Z-statistic, two-sided 




Supplementary Table 6: Genetic correlations of psychiatric disorders with educational attainment 
Sample 1 Sample 2 rg (SE) P 
EA(SSGAC) 
ASD(iPSYCH, woADHD) 0.23(0.03) <10-10 
ASD(PGC) 0.28(0.03) <10-10 
ADHD(iPSYCH) -0.49(0.03) <10-10 
MDD(PGC) -0.22 (0.03) <10-10 
SCZ(PGC) 0.07 (0.02) 0.003 
BD(PGC) 0.18 (0.02) <10-10 
ASD(iPSYCH, woADHD) + ADHD(iPSYCH) -0.23(0.03) <10-10 
ASD(PGC) + ADHD(iPSYCH) -0.38(0.03) <10-10 
ASD(iPSYCH, woADHD) + MDD(PGC) -0.13(0.03) 4x10-7 
ADHD(iPSYCH) + BD(PGC) -0.18(0.03) <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; EA; 
educational attainment; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; MDD, Major 
Depressive Disorder; PGC, Psychiatric Genomics Consortium; rg, genetic correlation; SCZ, Schizophrenia; SSGAC, Social Science 
Genetic Association Consortium; woADHD, without ADHD 
Genetic correlations (rg) were estimated using summary statistics and unconstrained LD score correlation1. Individual genetic 
correlation estimates, standard errors and corresponding P-values (Z-statistic, two-sided test) are shown. The multiple testing 
threshold was P<0.002. 
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Supplementary Table 7: Follow-up ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05), analyses with ASD(PGC) SNP estimates (independent variable) 
ASD-MVR 
Variant selection Intercept ASD effects ADHD effect 
VIF 
MVR to UVR model fit 
comparison 








-6x10-5(10-4) 0.69 0.010(0.003) 0.004 - - - 
-5x10-5(10-4) 0.70 0.010(0.003) 0.003 -0.003(0.003) 0.31 1.00 0.05 2.98, 0.31 
33,845 0.05 
-10-5(3x10-5) 0.61 0.005(0.001) <10-10 - - - 
-9x10-6(3x10-5) 0.76 0.005(0.001) <10-10 -0.007(0.001) <10-10 1.00 0.41 285.63, <10-10 
ADHD-MVR 
Variant selection Intercept ADHD effect ASD effect 
VIF 
MVR to UVR model fit 
comparison 




-0.001(2x10-4) <10-10 -0.004(0.003) 0.14 - - - 
-0.001(2x10-4) <10-10 -0.004(0.003) 0.13 0.002(0.002) 0.35 1.00 0.03 2.62, 0.35 
38,656 0.05 
-0.001(4x10-5) <10-10 -0.005(0.001) <10-10 - - - 
-0.001(4x10-5) <10-10 -0.005(0.001) <10-10 0.003(4x10-4) <10-10 1.00 0.16 123.59, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number of SNPs; PGC, Psychiatric Genomics Consortium; Pthr, P-value threshold; VIF, variance inflation factor; UVR, 
univariable regression; ∆R2, difference in Regression R2 between MVR and UVR 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Supplementary Figure 1c). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-
MVR (Supplementary Figure 1d). Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics respectively and 
are shown for two P-value thresholds (Pthr<0.0015, Pthr<0.05). SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(PGC), ADHD(iPSYCH) and EA(SSGAC) GWAS 
statistics respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual effect estimates, standard errors and 





Supplementary Table 8: Follow-up ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05) with ASD(PGC) SNP estimates (independent variable), concordant variants 
ASD-MVR 
Variant selection Intercept ASD effect ADHD effect VIF 
MVR to UVR model fit comparison 
ASD UVR ADHD UVR 
Concordant 
variants Gi 









2x10-4(2x10-4) 0.29 0.009(0.005) 0.061 - - - 
0.001(2x10-4) 6x10-9 - -0.026(0.006) 9x10-6 - - 
0.001(3x10-4) 2x10-4 0.015(0.005) 0.003 -0.030(0.006) 6x10-7 1.05 2.7 78.55, 5x10-7 0.9 27.5, 0.003 
17,506 0.05 
-2x10-4(4x10-5) 4x10-6 0.005(9x10-4) 7x10-9 - - - 
2x10-4(4x10-5) 6x10-9 - -0.011(0.001) <1x10-10 - - 
6x10-5(5x10-5) 0.19 0.007(0.001) <1x10-10 -0.013(0.001) <1x10-10 1.05 0.5 194.9, <10-10 0.3 126.2, <10-10 
ADHD-MVR 
Variant selection Intercept ADHD effects ASD effect VIF 
MVR to UVR model fit comparison 
ADHD UVR ASD UVR 
Concordant 
variants Gj 




-0.001(3x10-4) 3x10-4 -0.008(0.004) 0.022 - - - 
-0.001(2x10-4) <1x10-10 - -0.005(0.004) 0.19 - - 
-0.001(3x10-4) 4x10-4 -0.008(0.004) 0.053 -0.002(0.004) 0.67 1.19 0.01 0.52, 0.67 0.3 10.8, 0.05 
19,615 0.05 
-4x10-4(6x10-5) 1x10-10 -0.006(0.001) 9x10-10 - - - 
-0.001(4x10-5) <1x10-10 - 2x10-4(0.001) 0.80 - - 
-4x10-4(6x10-5) <1x10-10 -0.008(0.001) <1x10-10 0.003(0.001) 0.003 1.19 0.05 18.15, 0.003 0.2 94.9, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number of SNPs; Pthr, P-value threshold; VIF, variance inflation factor; woADHD, without ADHD; UVR, univariable 
regression; ∆R2, difference in Regression R2 between UVR and MVR.  
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Supplementary Figure 1c). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-
MVR (Supplementary Figure 1d). Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected at two P-value thresholds (Pthr<0.0015, Pthr<0.05) from ASD(iPSYCH, woADHD) and 
ADHD(iPSYCH) GWAS statistics respectively. SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(PGC), ADHD(iPSYCH) and EA(SSGAC) GWAS statistics respectively 
and analyses were restricted to concordant ASD and ADHD SNP estimates. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual 
effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0125. The model fit of MVRs and UVRs was 
compared with likelihood-ratio tests (LRTs).  
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Supplementary Table 9: ASD-MVR and ADHD-MVR with variants from LD blocks with high posterior probability for pleiotropy 
ASD-MVR 
Variant selection Intercept ASD effects ADHD effect VIF MVR to UVR model fit comparison 
Gi NSNPs 𝜃𝜃�0*(SE) P 𝜃𝜃�ASD(SE) P 𝜃𝜃�*ADHD(SE) P  ∆R2(%) LRT-χ2(df=1), P  
ASD 
(iPSYCH, woADHD) 465 
0.001(5x10-4) 0.005 0.004(0.009) 0.67 - - - 
0.001(5x10-4) 0.004 0.027(0.010) 0.009 -0.042(0.008) 2x10-7 1.22 5.6 95.67, 2x10-7 
ADHD-MVR 
Variant selection Intercept ADHD effect ASD effect VIF MVR to UVR model fit comparison 
Gj NSNPs 𝜃𝜃�0#(SE) P 𝜃𝜃�ADHD(SE) P 𝜃𝜃�#ASD(SE) P  ∆R2(%) LRT-χ2(df=1), P  
ADHD 
(iPSYCH) 481 
6x10-5(5x10-5) 0.90 -0.015(0.009) 0.099 - - - 
7x10-6(5x10-4) 0.99 -0.037(0.010) 2x10-4 0.043(0.008) 2x10-8 1.18 6.3 112.17, 1x10-8 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number 
of SNPs; PPA; posterior probability; VIF, variance inflation factor; UVR, univariable regression; ∆R2, difference in Regression R2 between UVR and MVR 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Supplementary Figure 1e). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-
MVR (Supplementary Figure 1f). Approximately independent LD blocks with evidence for pleiotropy or high-LD co-localisation were identified using gwas-pw2 (posterior probability > 0.9) and 
ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics. Within each LD block, independent ASD- and ADHD-related variants (LD-r2<0.25 within ±500 kb) were identified using information from 
ASD(iPSYCH, woADHD) and ADHD(iPSYCH). SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) and EA(SSGAC) GWAS statistics 
respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or ADHD liability. Individual effect estimates, standard errors and corresponding P-
values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0023.The model fit of MVRs and UVRs was compared with likelihood-ratio tests (LRTs).   
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Supplementary Table 10: Identification of single variants using conditional P-value thresholding: ASD-MVR  
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; NSNPs, number of 
SNPs; Pthr, P-value threshold; woADHD, without ADHD; +Discovery ASD variant set (Pthr ASD<0.0015) 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on EA as fitted with ASD-MVR (Figure 4a, Supplementary Figure 1g) using six SNP subsets (Gi|j) fulfilling joint ASD and ADHD selection criteria. 
Independent genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics. Among ASD variants of the discovery variant set (+, Pthr<0.0015), we identified those 
SNPs, which were also associated with ADHD (six thresholds: 0.0015≤ADHD-Pthr<0.5). Variants were identified as tagged, if SNPs were within 500kb and LD-r2≥0.6. SNP estimates for ASD (?̂?𝛽ASD), 
ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) and EA(SSGAC) GWAS statistics respectively. All MVR effects are presented as change in years of schooling 
per increase in log odds of ASD or ADHD liability. Individual effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted 
threshold is P<0.0023.  
 
Variant selection  Intercept ASD effect ADHD effect 






0.0015 -0.003(0.001) 0.010 0.15(0.025) 10-7 -0.15(0.025) 10-7 
134 6.79 0.005 -0.002(0.001) 0.15 0.12(0.022) 6x10-7 -0.13(0.024) 2x10-7 
393 19.92 0.05 -0.001(0.001) 0.28 0.045(0.009) 4x10-7 -0.063(0.011) 7x10-9 
536 27.17 0.1 -4x10-4(5x10-4) 0.40 0.040(0.007) 2x10-8 -0.059(0.009) <10-10 
805 40.80 0.3 5x10-4(4x10-4) 0.21 0.021(0.005) 4x10-5 -0.044(0.006) <10-10 
914 46.33 0.5 0.001(3x10-4) 0.12 0.017(0.004) 10-4 -0.039(0.006) <10-10 
1973+ 100 1 0.001(2x10-4) 0.008 0.009(0.003) 0.002 -0.029(0.004) <10-10 
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Supplementary Table 11: Identification of single variants using conditional P-value thresholding: ADHD-MVR  
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; NSNPs, number of 
SNPs; Pthr, P-value threshold; woADHD, without ADHD; +Discovery ADHD variant set (Pthr ADHD<0.0015) 
 
Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on EA as fitted with ADHD-MVR (Figure 4b, Supplementary Figure 1h) using SNP subsets (Gj|i) fulfilling joint ASD and ADHD selection criteria. 
Independent genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics. Among ADHD variants of the discovery variant set (+, Pthr<0.0015), we identified those 
SNPs, which were also associated with ASD (six thresholds: 0.0015≤ ASD-Pthr <0.5). Variants were identified as tagged, if SNPs were within 500kb and LD-r2≥0.6. SNP estimates for ASD (?̂?𝛽ASD), ADHD 
(?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) and EA(SSGAC) GWAS statistics respectively. All MVR effects are presented as change in years of schooling per 
increase in log odds of ASD or ADHD liability. Individual effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold 
is P<0.0023.. 
Variant sets (Gj|i) Intercept ADHD effect ASD effect 





0.0015 -0.003(0.001) 0.038 -0.10(0.026) 2x10-4 0.12(0.022) 9x10-7 
145 5.34 0.005 -0.002(0.001) 0.050 -0.070(0.022) 0.002 0.086(0.019) 10-5 
473 17.41 0.05 -0.001(0.001) 0.044 -0.026(0.010) 0.010 0.032(0.010) 0.001 
638 23.48 0.1 -0.001(4x10-4) 0.047 -0.023(0.008) 0.003 0.026(0.008) 0.001 
937 34.49 0.3 -0.001(3x10-4) 0.003 -0.018(0.005) 5x10-4 0.023(0.006) 5x10-5 
1020 37.54 0.5 -0.001(3x10-4) 0.005 -0.017(0.005) 3x10-4 0.018(0.005) 3x10-4 
2717+ 100 1 -0.002(2x10-4) <10-10 -0.012(0.003) 4x10-5 0.022(0.003) <10-10 
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Supplementary Table 12: Permutation analysis 
ASD-MVR 
Variant selection Empirical P-value (SE) 
Pthr ASD  Pthr ADHD NSNPs 
ASD effect  
(𝜽𝜽�ASD) 
ADHD effect  
(𝜽𝜽�*ADHD) 
0.0015 0.0015 83 <10-4(<10-4) 7x10-4(3x10-4) 
ADHD-MVR 
Variant selection Empirical P-value (SE) 
Pthr ASD  Pthr ADHD NSNPs 
ADHD effect 
(𝜽𝜽�ADHD) 
ASD effect  
(𝜽𝜽�#ASD) 
0.0015 0.0015 83 9x10-4(3x10-4) 2x10-4(10-4) 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck 
Foundation Initiative for Integrative Psychiatric Research; NSNPs, number of SNPs; Pthr, P-value threshold; woADHD, without 
ADHD 
 
For each permutation, 83 independent SNPs were either randomly selected from Gi (Pthr<0.0015), for ASD-MVR, or Gj 
(Pthr<0.0015), for ADHD-MVR, based on ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics, respectively. Corresponding 
SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD), ADHD(iPSYCH) and 
EA(SSGAC) GWAS statistics, respectively. For both, empirical ASD-MVR and ADHD-MVR analyses, 10,000 permutations were 
carried out, in total.  
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Supplementary Table 13: Gene-set enrichment analysis 




1143 9 0.047 
PIK3R3, VAV3, KIF26B, TMOD3, 
EDAR, TGFBR2, RHOA, EXOC4, TEK 
GO_bp GO_RESPONSE_TO_HORMONE 968 8 0.047 PIK3R3, CHRM3, MYO5A, ATP6V1C2, 




1627 10 0.047 
PIK3R3, CHRM3, MYO5A, ATP6V1C2, ERBB4, 




1030 8 0.047 
PIK3R3, VAV3, ATP6V1C2, ERBB4, 




1366 9 0.047 
PIK3R3, CHRM3, MYO5A, ATP6V1C2, 




1069 8 0.047 
PIK3R3, VAV3, RANBP2, EDAR, ERBB4, 
TGFBR2, RHOA, TEK 
GO_bp 
GO_ORGANOPHOSPHATE_METABOLIC_ 
PROCESS 529 6 0.047 PIK3R3, VAV3, FMO2, IP6K2, RHOA, TEK 
GWAS Catalog Intelligence (MTAG) 313 6 4.8x10-3 
SCG3, ERBB4, BSN, CACNA2D2, 
LINC00461, EXOC4 
GWAS Catalog Morning person 201 5 5.0x10-3 IP6K2, RHOA, BSN, CACNA2D2, CSMD1 
GWAS Catalog General cognitive ability 242 5 8.1x10-3 IP6K2, RHOA, BSN, LINC00461, EXOC4 
GO_cc GO_GLUTAMATERGIC_SYNAPSE 348 5 0.024 CHRM3, MYO5A, ERBB4, RHOA, BSN 
GO_cc GO_SYNAPSE 1164 8 0.024 CHRM3, CACNA1C, MYO5A, ERBB4, 
VWC2L, RHOA, BSN, EXOC4 
GO_cc GO_POSTSYNAPSE 608 6 0.024 
CHRM3, CACNA1C, MYO5A, ERBB4, 
RHOA, BSN 
GO_cc GO_RECEPTOR_COMPLEX 397 5 0.024 PKD2L1, ERBB4, VWC2L, TGFBR2, TEK 
GO_cc GO_CELL_JUNCTION 1263 8 0.024 
CHRM3, CACNA1C, TMOD3, VWC2L, 
IP6K2, RHOA, BSN, TEK 
microRNA_targets TTTGCAC_MIR19A_MIR19B 515 7 7.7x10-4 
PIK3R3, KIAA1217, CACNA1C, ERBB4, 
TGFBR2, BSN, CSMD1 
microRNA_targets ACCAAAG_MIR9 500 5 0.028 PIK3R3, VAV3, KIAA1217, RANBP2, AUH 
Gene-set enrichment (>5 overlapping genes, FDR-adjusted P-values) was conducted with respect to pre-defined gene-sets derived from the Molecular Signature Database (v7.0), WikiPathways 
(v.20191010), or the GWAS Catalog (v.e96_r2019-09-24). Enrichment analysis was carried out with MAGMA3 (v1.08) using a one-sided hypergeometric test, as implemented in FUMA4 software 
(v1.3.6a), by mapping identified genes for the 83 loci to unique Ensembl IDs (v92). The False Discovery Rate (FDR) was controlled using the Benjamini Hochberg procedure (FUMA, v1.3.6a). 
19 
 
Supplementary Table 14: Sample description for MDD, SCZ, BD and general intelligence  
Source GWAS Consortium Imputation reference panel N  
Clinical 
sample 
MDD5 PGC 1000 Genomes multi-ancestry 
173,005 
(cases=59,851) 
SCZ6 PGC 1000 Genomes phase 3 
65,967 
(cases=33,426) 





7 CTG lab HRC# 279,930 
# Predominantly HRC, see Savage et al.7 
Abbreviations: BD, Bipolar Disorder; CTG, Complex Trait Genetics lab; HRC, Haplotype Reference Consortium; MDD, Major 
Depressive Disorder; PGC, Psychiatric Genomics Consortium; SCZ, Schizophrenia 
All individuals were of European descent.  
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Supplementary Table 15: Specificity analyses related to general intelligence (dependent variable) using ASD-MVR and ADHD-MVR (Pthr<0.0015; Pthr<0.05) 
ASD-MVR 
Variant selection Intercept ASD effect ADHD effect 
VIF 
MVR to UVR model fit 
comparison 





0.001(3x10-4) 0.01 -0.002(0.004) 0.59 - - - 
0.001(3x10-4) 0.008 0.008(0.004) 0.05 -0.033(0.005) 5x10-10 1.18 2.02 79.80, 4x10-10 
34,626 0.05 
4x10-4(7x10-5) 5x10-9 5x10-5(0.001) 0.96 - - - 
4x10-4(7x10-5) 5x10-10 0.006(0.001) 2x10-8 -0.021(0.001) <10-10 1.11 0.91 509.13, <10-10 
ADHD-MVR 
Variant selection Intercept ADHD effect ASD effect 
VIF 
MVR to UVR model fit 
comparison 




-0.001(3x10-4) 0.001 -0.006(0.004) 0.09 - - - 
-0.001(3x10-4) 0.001 -0.012(0.004) 0.002 0.016(0.004) 2x10-4 1.18 0.55 29.57, 10-4 
39,767 0.05 
-6x10-4(6x10-5) <10-10 -0.003 (0.001) 0.003 - - - 
-0.001(6x10-5) <10-10 -0.007(0.001) 3x10-10 0.012(0.001) <10-10 1.10 0.33 211.34, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; LRT, likelihood-ratio test; MVR, multivariable regression; NSNPs, number of SNPs; Pthr, P-value threshold; woADHD, without ADHD; UVR, univariable regression; ∆R2, difference in Regression 
R2 between MVR and UVR 
 
Estimated ASD effect (𝜃𝜃�ASD) and ADHD effect (𝜃𝜃�*ADHD) on general intelligence as fitted with ASD-MVR (Supplementary Figure 1i). Estimated ADHD effect (𝜃𝜃�ADHD) and ASD effect (𝜃𝜃�#ASD) on general 
intelligence as fitted with ADHD-MVR (Supplementary Figure 1j). Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS 
statistics respectively and are shown for two P-value thresholds (Pthr<0.0015, Pthr<0.05). SNP estimates for ASD (?̂?𝛽ASD), ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽Intelligence) were extracted from ASD(iPSYCH, 
woADHD), ADHD(iPSYCH) and intelligence (CTG lab) GWAS statistics respectively. All MVR effects are presented as standard deviation-related changes in general intelligence per increase in log 
odds of ASD or ADHD liability. Individual effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is 
P<0.0125.The model fit of MVRs and UVRs was compared with likelihood-ratio tests (LRTs). 
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Supplementary Table 16: Specificity analyses related to risk for other psychiatric disorders (independent variable), ASD-MVR (Pthr<0.0015; Pthr<0.05) 
Variant selection Intercept ASD effect Other disorder effect 
VIF 
MVR to UVR model fit 
comparison 












0.001(10-4) 3x10-5 -0.001(0.002) 0.45 - - - 
0.001(2x10-4) 3x10-5 -0.001(0.002) 0.55 𝜃𝜃�*MDD=-0.004(0.006) 0.46 1.04 0.02 1.37, 0.45 
50,904 0.05 
3x10-4 (4x10-5) <10-10 7x10-4(5x10-4) 0.13 - - - 
3x10-4(4x10-5) <10-10 0.001(5x10-4) 0.002 𝜃𝜃�*MDD=-0.012(0.001) <10-10 1.02 0.29 264.96, <10-10 
1,786 0.0015 
0.001(3x10-4) 0.01 -0.001(0.003) 0.78 - - - 
0.001(3x10-4) 0.02 -0.001(0.003) 0.83 𝜃𝜃�*SCZ=0.016(0.004) 3x10-4 1.00 0.71 37.92, 3x10-4 
31,026 0.05 
2x10-4(5x10-5 6x10-5 0.002(8x10-4) 0.01 - - - 
2x10-4(5x10-5) 10-4 0.002(0.001) 0.02 𝜃𝜃�*SCZ =0.006(0.001) 3x10-9 1.00 0.11 73.31, 3x10-9 
1,859 0.0015 
0.001(2x10-4) 0.003 -0.001(0.003) 0.61 - - - 
0.001(2x10-4) 0.004 -0.001(0.003) 0.61 𝜃𝜃�*BD=0.019(0.004) 6x10-7 1.00 1.33 71.40, 6x10-7 
32,367 0.05 
2x10-4(5x10-5) 2x10-6 0.002(7x10-4) 0.04 - - - 
2x10-4(5x10-5) 7x10-6 0.002(0.001) 0.033 𝜃𝜃�*BD =0.009(0.001) <10-10 1.00 0.41 272.24, <10-10 
Abbreviations: ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; LRT, likelihood-ratio 
test; MDD; Major Depressive Disorder; MVR, multivariable regression; PGC, Psychiatric Genomics Consortium; SCZ, Schizophrenia; Pthr, P-value threshold; woADHD; without ADHD; UVR, univariable 
regression; ∆R2, difference in Regression R2 between MVR and UVR 
 
Estimated ASD effect (𝜃𝜃�ASD), MDD (𝜃𝜃�*MDD), SCZ (𝜃𝜃�*SCZ) and BD (𝜃𝜃�*BD) effects on EA as fitted with ASD-MVR (Supplementary Figure 1k, Supplementary Figure 5a). Sets of independent ASD (Gi) genetic 
variants were selected from ASD(iPSYCH, woADHD) and are shown for two P-value thresholds (Pthr<0.0015, Pthr<0.05). SNP estimates ?̂?𝛽ASD, ?̂?𝛽MDD, ?̂?𝛽SCZ, ?̂?𝛽BD and ?̂?𝛽EA were extracted from ASD(iPSYCH, 
woADHD), MDD(PGC), SCZ(PGC), BD(PGC) and EA(SSGAC) GWAS statistics, respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ASD or MDD, SCZ 
or BD liability. Individual effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0042. The model fit of 
MVRs and UVRs was compared with likelihood-ratio tests (LRTs).  
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Supplementary Table 17: Specificity analyses related to risk for other psychiatric disorders (independent variable), ADHD-MVR (Pthr<0.0015; Pthr<0.05) 
Variant selection Intercept ADHD effect Other disorder effect 
VIF 
MVR to UVR model fit 
comparison 









-0.001(2x10-4) <10-10 -0.005(0.003) 0.11 - - - 
-0.001(2x10-4) 4x10-10 -0.002(0.003) 0.56 𝜃𝜃�#MDD=-0.033(0.007) 5x10-7 1.04 0.98 76.87, 4x10-7 
38,093 0.05 
-0.001(4x10-5) <10-10 -0.005(0.001) 10-10 - - - 
-0.001(4x10-5) <10-10 -0.004(0.001) 5x10-7 𝜃𝜃�#MDD=-0.013(0.001) <10-10 1.02 0.23 181.10, <10-10 
2,278 0.0015 
-0.001(3x10-4) 7x10-7 -0.007(0.004) 0.056 - - - 
-0.001(3x10-4) 9x10-7 -0.007(0.004) 0.059 𝜃𝜃�#SCZ=-0.006(0.004) 0.14 1.00 0.09 6.91, 0.14 
31,395 0.05 
-0.001(5x10-5) <10-10 -0.007(0.001) <10-10 - - - 
-0.001(5x10-5) <10-10 -0.007(0.001) <10-10 𝜃𝜃�#SCZ=0.003(0.001) 0.007 1.00 0.02 16.21, 0.007 
2,340 0.0015 
-0.001(2x10-4) 10-7 -0.007(0.003) 0.040 - - - 
-0.001(2x10-4) 8x10-8 -0.007(0.003) 0.042 𝜃𝜃�#BD=0.007(0.004) 0.046 1.00 0.17 12.56, 0.046 
32,788 0.05 
-0.001(5x10-5) <10-10 -0.007(0.001) <10-10 - - - 
-0.001(5x10-5) <10-10 -0.007(0.001) <10-10 𝜃𝜃�#BD=0.008(0.001) <10-10 1.00 0.29 205.72, <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; BD, Bipolar Disorder; df, degrees of freedom; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; LRT, 
likelihood-ratio test; MDD; Major Depressive Disorder; MVR, multivariable regression; PGC, Psychiatric Genomics Consortium; SCZ, Schizophrenia; Pthr, P-value threshold; woADHD; without ADHD; 
UVR, univariable regression; ∆R2, difference in Regression R2 between MVR and UVR 
 
Estimated ADHD (𝜃𝜃�ADHD), MDD (𝜃𝜃�#MDD), SCZ (𝜃𝜃�#SCZ) and BD (𝜃𝜃�#BD) effect on EA as fitted with ADHD-MVR (Supplementary Figure 1l, Supplementary Figure 5b). Sets of independent ADHD (Gj) genetic 
variants were selected from ADHD(iPSYCH) and are shown for two P-value thresholds (Pthr<0.0015, Pthr<0.05). SNP estimates ?̂?𝛽ADHD, ?̂?𝛽MDD, ?̂?𝛽SCZ, ?̂?𝛽BD and ?̂?𝛽EA were extracted from ADHD(iPSYCH), 
MDD(PGC), SCZ(PGC), BD(PGC) and EA(SSGAC) GWAS statistics, respectively. All MVR effects are presented as change in years of schooling per increase in log odds of ADHD or MDD, SCZ or BD 
liability. Individual effect estimates, standard errors and corresponding P-values (t-statistic, two-sided test) are shown. The multiple-testing-adjusted threshold is P<0.0042. The model fit of MVRs 
and UVRs was compared with likelihood-ratio tests (LRTs).  
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Supplementary Table 18: Genetic correlations of ASD and ADHD with general intelligence 
Sample 1 Sample 2 rg (SE) P 
Intelligence(CTG) 
ASD(iPSYCH, woADHD) 0.25(0.04) <10-10 
ASD(PGC) 0.19(0.04) 2x10-7 
ADHD(iPSYCH) -0.33(0.03) <10-10 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; CTG, Complex Trait Genetics 
lab; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; PGC, Psychiatric Genomics Consortium; 
rg, genetic correlation; woADHD, without ADHD; 
Genetic correlations (rg) with intelligence were estimated using summary statistics and unconstrained LD score correlation1. 
Individual genetic correlation estimates, standard errors and corresponding P-values (Z-statistic, two-sided test) are shown. 
The multiple testing threshold was P<0.002. 
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Supplementary Table 19: SNP-heritability estimates 
Phenotype Sample SNP-h2 (SE) λGC Intercept (SE) 
ASD 
ASD(iPSYCH, woADHD) 0.13(0.01) 1.13 1.01(0.01) 
ASD(PGC) 0.26(0.03) 1.05 0.97(0.01) 
ADHD ADHD(iPSYCH) 0.26(0.02) 1.23 1.03(0.01) 
MDD MDD(PGC) 0.095(0.01) 1.24 0.99(0.01) 
SCZ SCZ(PGC) 0.24(0.01) 1.50 1.05(0.01) 
BD BD(PGC) 0.18(0.01) 1.27 1.02(0.01) 
Years of schooling EA(SSGAC) 0.11(0.003) 2.10 1.03(0.01) 
General intelligence Intelligence(CTG) 0.18(0.006) 1.75 1.08(0.01) 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; EA; 
educational attainment; CTG, Complex Trait Genetics lab; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; MDD, Major Depressive Disorder; PGC, Psychiatric Genomics Consortium; SCZ, Schizophrenia; SSGAC, Social Science 
Genetic Association Consortium; λGC, lambda GC; woADHD, without ADHD 
SNP-heritability (SNP-h2) was estimated with LD score regression analysis8. SNP-h2 estimates for EA and general intelligence 
were calculated on the observed scale and for psychiatric disorders on a liability scale assuming a population prevalence of 









Supplementary Figure 1: MVR study design  
Acyclic graphs illustrating the multivariable regression (MVR) design applied at different stages of the study detailing GWAS 
statistics for both, variant set selection and SNP estimate (?̂?𝛽) extraction. For ASD-MVR, a set of ASD-related variants (Gi) and 
for ADHD MVR, a set of ADHD-related variants (Gj) was selected at different P-value thresholds (Pthr) as shown for (a-b) 
discovery analyses, (c-d) follow-up analyses, (e-f) gwas-pw analyses, (g-h) the identification of single variants with conditional 
P-value thresholding analyses (using subsets of Gi and Gj, i.e. Gi|j and Gj|i) and (i-l) specificity analyses, including (i-j) general 
intelligence as dependent variable and (k-l) risk for other psychiatric disorder (MDD, SCZ, BD) as independent variables. For 
GWAS-pw analyses (e-f), ASD-related and ADHD-related variants were selected from linkage disequilibrium (LD) blocks with 
high posterior probability (>0.9) for pleiotropy or, equivalently, high-LD co-localisation; variants within high-confidence regions 
were pruned for LD (LD-r2<0.25 within ±500 kb) without applying P-value thresholding. MVR effects are denoted by 𝜃𝜃� and 
MVR intercepts by 𝜃𝜃�0. “*” Estimation of polygenic risk effects using alleles that were selected to increase liability for ASD, but 
are shared, by position, with risk alleles for other disorders; “#” Estimation of polygenic risk effects using alleles that were 
selected to increase liability for ADHD, but are shared, by position, with risk alleles for other disorders.  
 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; EA, 
Educational attainment, GWAS, genome-wide association study, iPSYCH, The Lundbeck Foundation Initiative for Integrative 
Psychiatric Research; MDD; Major Depressive Disorder; MVR, multivariable regression; Pthr, P-value threshold; PGC, Psychiatric 




Supplementary Figure 2: Bivariate analyses of ASD, ADHD and EA genetic effects using ASD and ADHD concordant variant sets 
Sets of independent ASD-related (Gi) and ADHD-related (Gj) genetic variants were selected from ASD(iPSYCH, woADHD) and ADHD(iPSYCH) GWAS statistics respectively (Pthr<0.05). SNP estimates for ASD (?̂?𝛽ASD), 
ADHD (?̂?𝛽ADHD) and EA (?̂?𝛽EA) were extracted from ASD(iPSYCH, woADHD; N=32,985) and ADHD(iPSYCH; N=37,076) and EA(SSGAC; N=766,345) GWAS statistics respectively. Only genetic variants with the same risk-
increasing allele for both ASD and ADHD (concordant variants) were included. (a-c) Using univariable weighted regression models for ASD variants (Gi), (a) ADHD SNP estimates (?̂?𝛽ADHD) were regressed on ASD SNP 
estimates (?̂?𝛽ASD), (b) EA SNP estimates (?̂?𝛽EA) were regressed on ASD SNP estimates (?̂?𝛽ASD), and (c) EA SNP estimates (?̂?𝛽EA) were regressed on ADHD SNP estimates (?̂?𝛽ADHD). (d-f) Using univariable weighted regression 
models and ADHD variants (Gj), (d) ADHD SNP estimates (?̂?𝛽ADHD) were regressed on ASD SNP estimates (?̂?𝛽ASD), (e) EA SNP estimates (?̂?𝛽EA) were regressed on ASD SNP estimates (?̂?𝛽ASD), and (f) EA SNP estimates (?̂?𝛽EA) 
were regressed on ADHD SNP estimates (?̂?𝛽ADHD). All regressions allowed for an intercept. A green regression line denotes a positive relationship between SNP estimates, a blue regression line reflects no significant 
relationship and a red line indicates a negative relationship. Regression estimates (𝜃𝜃�), corresponding standard errors (SE) and P-values are shown for each regression model. Source data are provided as a Source 
Data file. 




Supplementary Figure 3: Evidence for pleiotropy and co-localisation using gwas-pw  
gwas-pw analyses9 were carried out using GWAS summary statistics without applying P-value selection criteria for (a) 
ASD(iPSYCH,woADHD; N=32,985) and ADHD(iPSYCH; N=37,076) summary statistics, and (b) ASD(PGC; N=10,610) and 
ADHD(iPSYCH; N=37,076) summary statistics. After dividing the genome into approximately independent LD blocks, gwas-pw 
estimates the posterior probability that a given LD block contains a genetic variant associated with ASD (model 1), a genetic 
variant associated with ADHD (model 2), a genetic variant associated with both disorders, reflecting biological pleiotropy or 
high-LD co-localisation (model 3), or multiple genetic variants that are each associated with a different disorder (co-localisation 
in the presence of low/moderate LD, model 4). Evidence for model 3 and model 4 was evaluated at a stringent posterior 
probability threshold (>0.9), indicated by a black horizontal line in each plot. Source data are provided as a Source Data file. 
 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; iPSYCH, The Lundbeck 
Foundation Initiative for Integrative Psychiatric Research; PGC, Psychiatric Genomics Consortium; PPA, posterior probability; 





Supplementary Figure 4: Genes annotated within pleiotropic genomic segments 
Approximately independent LD blocks with evidence for pleiotropy and/or co-localisation (posterior probability > 0.9), were 
identified using gwas-pw analyses9 and summary statistics for ASD(iPSYCH,woADHD) and ADHD(iPSYCH). Genes annotated 
within these regions were identified using UCSC genome browser10. (a) chromosome 1: 96151539-97885200 bp, (b) 





Supplementary Figure 5: Cross-disorder associations with educational attainment for other disorders 
Acyclic graphs illustrating the multivariable regression (MVR) design for (a) a set of independent ASD-related variants Gi (ASD-
MVR) and (b) a set of independent ADHD-related variants Gj (ADHD-MVR). For ASD-MVR (a), ASD-increasing marker alleles (Gi) 
were aligned to ASD (?̂?𝛽ASD), MDD (?̂?𝛽MDD), SCZ (?̂?𝛽SCZ), BD (?̂?𝛽BD) and EA (?̂?𝛽EA), capturing genetic association at the single variant 
level. Using the MVR framework, the aggregate association effect with EA across all variants was simultaneously estimated for 
ASD risk (θASD) and other disorders (θ*MDD, θ*SCZ and θ*BD), including a regression intercept (θ0*). * Estimation of polygenic risk 
effects using alleles that were selected to increase liability for ASD, but are shared, by position, with risk for other disorders. 
(b) Likewise, for ADHD-MVR, increaser marker alleles (Gj) were aligned to ADHD (?̂?𝛽ADHD), MDD (?̂?𝛽MDD), SCZ (?̂?𝛽SCZ), BD (?̂?𝛽BD) and 
EA (?̂?𝛽EA) GWAS SNP estimates and aggregate association effect with EA across all variants simultaneously estimated for ADHD 
risk (θADHD) and other disorders (θ#MDD, θ#SCZ and θ#BD), including a regression intercept (θ0#). # Estimation of polygenic risk 
effects using alleles that were selected to increase liability for ADHD, but are shared, by position, with risk for other disorders. 
(c) ASD-MVR (𝜃𝜃�ASD; 𝜃𝜃�*MDD; 𝜃𝜃�*SCZ; 𝜃𝜃�*BD) and ADHD-MVR (𝜃𝜃�ADHD; 𝜃𝜃�#MDD; 𝜃𝜃�#SCZ; 𝜃𝜃�#BD) effects as change in years of schooling per 
increase in log odds of ASD or ADHD liability. Multivariate inverse-variance-weighted regression estimates and corresponding 
95% confidence intervals (bars) are shown. Individual effect estimates, standard errors and corresponding P-values (t-statistic, 
two-sided test) are provided in Supplementary Table 16-17. All effects passed the multiple testing threshold of P<0.0042, unless 
indicated otherwise (+).Sets of independent ASD (Gi) and ADHD (Gj) genetic variants were selected from ASD(iPSYCH, woADHD) 
and ADHD(iPSYCH) GWAS statistics respectively and are shown for P-value threshold (Pthr<0.05). SNP estimates ?̂?𝛽ASD, ?̂?𝛽ADHD, 
?̂?𝛽MDD, ?̂?𝛽SCZ, ?̂?𝛽BD and ?̂?𝛽EA were extracted from ASD(iPSYCH, woADHD; N=32,985), ADHD(iPSYCH; N=37,076), MDD(PGC; 
N=173,005), SCZ(PGC; N=65,967), BD(PGC; N=41,653) and EA(SSGAC; N=766,345) GWAS statistics respectively. Source data 
are provided as a Source Data file. 
 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; EA, 
Educational attainment, iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; MDD; Major 
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Depressive Disorder; MVR, multivariable regression; Pthr, P-value threshold; PGC, Psychiatric Genomics Consortium; SCZ, 




Supplementary Figure 6: Genetic correlations with EA for cross-disorder meta-analyses 
Genetic correlations (rg) of educational attainment (EA) with ASD, ADHD, BD, MDD, and combined ASD + MDD risk as well as 
combined ADHD + BD risk were estimated using unconstrained LD score correlation1. Genetic correlations with EA(SSGAC; 
N=766,345) were estimated for (a) ASD(iPSYCH, woADHD; N=32.985), MDD(PGC; N=173,005) and a combination of these 
summary statistics (cross-disorder meta-analysis), and, analogously, for (b) for ADHD(iPSYCH; N=37,076), BD(PGC; N=41,653) 
and a combination of these summary statistics (cross-disorder meta-analysis). Cross-disorder meta-analyses were conducted 
with METACARPA, allowing for sample overlap11. LDSC correlation estimates with 95% confidence intervals (bars) are shown. 
Individual genetic correlation estimates, standard errors and corresponding P-values (Z-statistic, two-sided test) are provided 
in Supplementary Table 6. All tests passed the multiple testing threshold of P<0.002. Source data are provided as a Source Data 
file. 
Abbreviations: ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; MDD, 
Major Depressive Disorder; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research; PGC, Psychiatric 
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